|

Parkinson's Disease Clinical Trials in New York

25 recruiting studies across 1 city

Browse by City

New York
25 trials

All Trials in New York

Phase
Trial Phase Dist.
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
Rehabilitation of Airway Protection in Parkinson's DiseasePhase 2<1 mi
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's DiseasePhase 1/2<1 mi
Drug Discovery for Parkinson's With Mutations in the GBA Gene—<1 mi
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.Phase 1/2<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications—<1 mi
Parkinson's Disease Biomarkers in Nerve Cells in the Gut—<1 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/3<1 mi
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's PatientsN/A<1 mi
Autoimmune Features of Neurodegenerative Disorders—<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—<1 mi
A Study of Buntanetap in Participants With PDPhase 2/3<1 mi
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's DiseaseEarly 1<1 mi
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 2<1 mi
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's DiseaseN/A<1 mi
NYSCF Scientific Discovery Biobank—<1 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—16 mi
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) PatientsN/A22 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—38 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 438 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.